Found 13 Enz. Inhib. hit(s) with all data for entry = 130 TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 550nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 550nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 550nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
